Daftar Isi:
  • AIDS (Acquired Immuno Deficiency Syndrome) is an infectious disease caused by HIV (Human Immunodeficiency Virus). It attacks white blood cells (lymphocytes), it causes lower immune system. A guidelines for HIV/AIDS is antiretroviral treatment. Metabolic disorders are common condition in HIV, either may affect lipid metabolism. Especially for those using first-line ARVs, such as efavirenz and nevirapine. Related to these conditions, then we were did this study to assess LDL cholesterol in HIV/AIDS patiens whose using first line therapy, especially efavirenz and nevirapine. This is prospectively study using comparative design to compare LDL cholesterol between efavirenz and nevirapine. The participants were HIV / AIDS patients who suitable with criteria. After analysis, patients taking efavirenz had 142.31 mg/dL ±41,461 LDL cholesterol, and nevirapine 126.83 mg/dL ±40,556. It means patients on efavirenz has higher LDL cholesterol than nevirapine. However, the difference was not statistically significant, with P= 0.119.